K2 Principal Fund’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History

K2 Principal Fund’s Portfolio NVLN Stock Details NVLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Hold	0	–	–	–	443
2017 Q3	–	Hold	0	–	–	–	498
2017 Q2	–	Sell	-49,350	Closed	-$530K	–	501
2017 Q1	$530K	Sell	49,350 -220,186	-82%	-$2.25M	0.09%	234
2016 Q4	$2.27M	Buy	+269,536	New	+$2.39M	0.42%	107

Other funds holding NVLN

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Broadfin Capital New York $403M AUM 100.56% 1-Year Est. Return

Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return

Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Healthcare Value Capital Woodcliff Lake, New Jersey $38.5M AUM 24.72% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return